首页|基于网络药理学和分子对接探究补中益气汤对视网膜色素变性作用机制及实验验证

基于网络药理学和分子对接探究补中益气汤对视网膜色素变性作用机制及实验验证

扫码查看
目的 基于网络药理学探讨补中益气汤治疗视网膜色素变性(RP)的机制,并通过体外实验进行验证.方法 通过检索TCMSP筛选补中益气汤组方药物活性成分及其对应靶点,检索GeneCards、OMIM数据库获取RP相关作用靶点,通过Cytoscape 3.7.1软件构建补中益气汤-RP相互作用网络,筛选核心靶点.应用DAVID在线数据库进行GO功能富集和KEGG通路富集分析;检索FerrDb数据库,获得铁死亡调控基因,综合探析补中益气汤活性靶点、RP及铁死亡之间关系并作出预测;通过AutoDock Vina 1.1.2软件进行分子对接,验证结果可靠性.体外实验以小鼠Muller细胞为研究对象,以脂多糖诱导细胞构建体外模型细胞,设置空白组、模型组、阳性对照组及补中益气汤低、中、高剂量组,采用CCK-8法检测细胞活力;使用试剂盒检测细胞中LDH、SOD、MDA水平和铁离子浓度;RT-PCR检测各组细胞中IL-6、HIF-1αmRNA及GPX-4、FTH-1、ACSL4 mRNA水平.结果 获得补中益气汤作用靶点117个,预测得到IL6、IL1β、EGFR、ESR1、PPARG等18个靶点可能是补中益气汤调控铁死亡抗RP的作用靶点,补中益气汤可通过介导MAPK、HIF-1、TNF、AGE-RAGE、Toll样受体、IL-17、PI3K-Akt等信号通路调控铁死亡.分子对接结果提示,补中益气汤中的槲皮素、山柰酚、β-谷甾醇与IL-6、IL-1β、EGFR、ESR1、PPARG等候选核心靶点间存在较好的结合活性.与模型组比较,补中益气汤各剂量组细胞活力、SOD活性增强(P<0.05),LDH活性、MDA水平、铁离子含量及IL-6、HIF-1 α、ACSL4 mRNA 水平降低(P<0.05),GPX-4、FTH-1 mRNA 水平升高(P<0.05).结论 补中益气汤可能通过多成分、多靶点,涉及多条分子通路发挥抗炎、抗铁死亡的作用,从而达到防治RP的作用.
Exploration on the mechanism and experimental verification of Buzhong Yiqi Decoction on retinitis pigmentosa based on network pharmacology and molecular docking
Objective To explore the mechanism of Buzhong Yiqi Decoction in the treatment of retinitis pigmentosa(RP)based on network pharmacology;To verify it by in vitro experiments.Methods The effective active components and corresponding targets of Buzhong Yiqi Decoction were screened by retrieving TCMSP database,and the RP-related targets were obtained by searching GeneCards,OMIM and other databases.The interaction network diagram of Buzhong Yiqi Decoction-RP was drawn by Cytascape3.7.1 software,and the core targets were extracted.DAVID online database was used to enrich and analyze gene ontology(GO)and Kyoto Encyclopedia of Genes and Genome(KEGG)pathway;the FerrDb database was searched to obtain the genes that regulate ferroptosis,and finally comprehensively analyze the relationship between the active targets of Buzhong Yiqi Decoction,RP and ferroptosis and make predictions;finally,molecular docking was performed by Auto Dock software to verify the reliability of the results.In vitro experiment,rat Muller cells were used as the research object,and LPS-induced cells were used to construct model cells in vitro.The blank group,model group,Buzhong Yiqi Decoction low-,medium-and high-dosage groups were set up,and the cell proliferation was detected by CCK-8 method;the concentrations of lactate dehydrogenase(LDH),superoxide dismutase(SOD),malondialdehyde(MDA)and ferroptosis in the cells were detected by the kit method;the expressions of HIF-1α MRNA and GPX-4,FTH-1,ACSL4 mRNA levels in cells of each group were detected by RT-PCR.Results Totally 117 effective targets were selected from Buzhong Yiqi Decoction,and IL-6,IL-1β,EGFR,ESR1,PPARG may be the targets of Buzhong Yiqi Decoction in regulating ferroptosis and anti-RP.Buzhong Yiqi Decoction could regulate ferroptosis by mediating MAPK,HIF-1,TNF,AGE-RAGE,Toll-like receptor,IL-17,PI3K-Akt and other signal pathways.Molecular docking virtual results suggested that the quercetin,kaempferol,β-Sitosterol and IL-6,IL-1β,EGFR,ESR1,PPARG and other candidate core targets had good binding activity.Compared with the model group,the cell activity,level of SOD,LDH activity,MDA content and Fe3+content,IL-6 mRNA,HIF1A mRNA,ACSL4 mRNA in each Buzhong Yiqi Decoction group significantly decreased(P<0.05),the expressions of GPX-4 and FTH-1mRNA significantly increased(P<0.05).Conclusion Buzhong Yiqi Decoction may play the role of anti-inflammation and anti-ferroptosis through multiple components,multiple targets and multiple molecular pathways,thus achieving the effect of prevention and treatment of RP.

Bu Zhong Yi Qi TangRetinal pigmentationFerroptosisNetwork pharmacologyMechanism

杨稀瑞、王继雪

展开 >

河南中医药大学第一附属医院眼科,郑州 450000

河南中医药大学第一附属医院周围血管科,郑州 450000

补中益气汤 视网膜色素变性 铁死亡 网络药理学 作用机制

国家自然科学基金国家自然科学基金河南省中医临床研究基地科研专项河南省中医临床研究基地科研专项

82205195822051172022JDZX1272022JDZX135

2024

国际中医中药杂志
中华医学会,中国中医科学院中医药信息研究所

国际中医中药杂志

CSTPCD
影响因子:0.411
ISSN:1673-4246
年,卷(期):2024.46(8)
  • 8